Giulia Puliani

Pubblicazioni

Titolo Pubblicato in Anno
NRF2 activation in BON‑1 neuroendocrine cancer cells reduces the cytotoxic effects of a novel Ruthenium(II)‑curcumin compound: A pilot study ONCOLOGY REPORTS 2024
Correction to: Neuroendocrine neoplasms in~the~context of~inherited tumor syndromes: a~reappraisal focused on~targeted therapies (Journal of Endocrinological Investigation, (2022), 10.1007/s40618-022-01905-4) JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Platelet-derived circRNAs signature in patients with gastroenteropancreatic neuroendocrine tumors JOURNAL OF TRANSLATIONAL MEDICINE 2023
Pituitary T1 signal intensity at magnetic resonance imaging is reduced in patients with obesity: results from the CHIASM study INTERNATIONAL JOURNAL OF OBESITY 2023
Correction: Pituitary T1 signal intensity at magnetic resonance imaging is reduced in patients with obesity: results from the CHIASM study INTERNATIONAL JOURNAL OF OBESITY 2023
Tall stature and gigantism in transition age: clinical and genetic aspects-a literature review and recommendations JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2023
Thyroid transcription factor-1 expression in lung neuroendocrine tumours: a gender-related biomarker? ENDOCRINE 2023
Predictive Factors of Response to Streptozotocin in Neuroendocrine Pancreatic Neoplasms JOURNAL OF CLINICAL MEDICINE 2023
Angiogenic factors as prognostic markers in neuroendocrine neoplasms ENDOCRINE 2022
Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2022
New Insights in PRRT: Lessons From 2021 FRONTIERS IN ENDOCRINOLOGY 2022
The Strange Case of a Pancreatic Neuroendocrine Carcinoma with Low Proliferation Index and Atypical Clinical Behavior PANCREAS 2022
Prognostic significance of laterality in lung neuroendocrine tumors ENDOCRINE 2022
Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials JOURNAL OF BONE AND MINERAL RESEARCH 2022
Sellar and parasellar lesions in the transition age: a retrospective Italian multi-centre study JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION 2022
Angioside: the role of angiogenesis and hypoxia in lung neuroendocrine tumours according to primary tumour location in left or right parenchyma JOURNAL OF CLINICAL MEDICINE 2022
Characterization of circulating immune cells and correlation with Tie2/Angiopoietins level in well differentiated neuroendocrine gastroenteropancreatic tumors: a cross-sectional analysis ENDOCRINE 2022
The Effects of Radioligand Therapy on Quality of Life and Sexual Function in Patients with Neuroendocrine Neoplasms CANCERS 2022
Syndrome of inappropriate antidiuresis and diabetes insipidus as two sides of the same coin in hypothalamic lymphoma: A case report ENDOCRINE, METABOLIC & IMMUNE DISORDERS DRUG TARGETS 2022
Characterization of circulating immune cells and correlation with Tie2/Angiopoietins level in well differentiated neuroendocrine gastroenteropancreatic tumors: a cross-sectional analysis ENDOCRINE 2022

ERC

  • LS4_4

KET

  • Life-science technologies & biotechnologies

Interessi di ricerca

 

My main clinical and traslational research interests are in the field of bone metabolism and neuroendocrinology, and in particular in neuroendocrine neoplasms and pituitary disease.

In addiction, also thanks to the collaboration with the oncological endocrinology unit of Regina Elena National Cancer Institute, I had the possibility to focus on endocrine neoplasms, including also thyroid and adrenal carcinomas, taking part also in observational and interventional clinical trials. 

Keywords

neuroendocrine neoplasia
Pituitary
bone metabolism
thyroid cancer

Gruppi di ricerca

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma